...
首页> 外文期刊>Clinical and vaccine immunology: CVI >Variability in the Distribution of Genes Encoding Virulence Factors and Putative Extracellular Proteins of Streptococcus pyogenes in India, a Region with High Streptococcal Disease Burden, and Implication for Development of a Regional Multisubunit Vaccine
【24h】

Variability in the Distribution of Genes Encoding Virulence Factors and Putative Extracellular Proteins of Streptococcus pyogenes in India, a Region with High Streptococcal Disease Burden, and Implication for Development of a Regional Multisubunit Vaccine

机译:在印度,一个高链球菌病负担的地区,化脓性链球菌致病因子和推测的胞外蛋白基因的分布中的变异性,以及对开发区域多亚基疫苗的意义

获取原文
           

摘要

Streptococcus pyogenes causes a wide variety of human diseases and is a significant cause of morbidity and mortality. Attempts to develop a vaccine were hampered by the genetic diversity of S. pyogenes across different regions of the world. This study sought to identify streptococcal antigens suitable for a region-specific vaccine in India. We used a two-step approach, first performing epidemiological analysis to identify the conserved antigens among Indian isolates. The second step consisted of validating the identified antigens by serological analysis. The 201 streptococcal clinical isolates from India used in this study represented 69 different emm types, with emm12 being the most prevalent. Virulence profiling of the North and South Indian S. pyogenes isolates with a custom-designed streptococcal virulence microarray identified seven conserved putative vaccine candidates. Collagen-like surface protein (SCI), putative secreted 5′-nucleotidase (PSNT), and C5a peptidase were found in 100% of the isolates, while R28, a putative surface antigen (PSA), and a hypothetical protein (HYP) were found in 90% of the isolates. A fibronectin binding protein, SfbI, was present in only 78% of the isolates. In order to validate the identified potential vaccine candidates, 185 serum samples obtained from patients with different clinical manifestations were tested for antibodies. Irrespective of clinical manifestations, serum samples showed high antibody titers to all proteins except for SCI and R28. Thus, the data indicate that PSNT, C5a peptidase, PSA, HYP, and SfbI are promising candidates for a region-specific streptococcal vaccine for the different parts of India.
机译:化脓性链球菌引起多种人类疾病,并且是发病率和死亡率的重要原因。化脓性链球菌在世界不同地区的遗传多样性阻碍了开发疫苗的尝试。这项研究试图确定适合印度区域性疫苗的链球菌抗原。我们采用了两步法,首先进行了流行病学分析,以鉴定印度分离株中的保守抗原。第二步包括通过血清学分析验证鉴定的抗原。本研究中使用的来自印度的201种链球菌临床分离株代表69种不同的 emm 类型,其中 emm 12最常见。用定制设计的链球菌毒力微阵列对印度北部化脓性链球菌和南印度化脓性链球菌的毒力谱进行了鉴定,确定了七种保守的候选疫苗。在100%的分离物中发现了胶原样表面蛋白(SCI),推定的5'-核苷酸酶(PSNT)和C5a肽酶,而R28,推定的表面抗原(PSA)和假设的蛋白(HYP)被发现。在90%的分离物中发现。纤连蛋白结合蛋白SfbI仅存在于78%的分离物中。为了验证鉴定出的潜在候选疫苗,对从具有不同临床表现的患者获得的185个血清样品进行了抗体测试。不论临床表现如何,血清样品对除SCI和R28以外的所有蛋白质均显示高抗体滴度。因此,数据表明PSNT,C5a肽酶,PSA,HYP和SfbI是印度不同地区的区域特异性链球菌疫苗的有希望的候选者。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号